...

首页> 外文期刊>European Journal of Cancer Supplements >5156 A tool to improve personalized cancer care: measuring the response of circulating epithelial tumour cells (CETC) and tumour stem cell subpopulations to therapy in the individual patient

【24h】

5156 A tool to improve personalized cancer care: measuring the response of circulating epithelial tumour cells (CETC) and tumour stem cell subpopulations to therapy in the individual patient

机译：5156一种改善个性化癌症护理的工具：测量循环上皮肿瘤细胞（CETC）和肿瘤干细胞亚群对个别患者治疗的反应

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2009年第2期|共2页
作者
K.Pachmann; O.Camara; I.B.Runnebaum; K.Hoeffken;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 5156 A tool to improve personalized cancer care: measuring the response of circulating epithelial tumour cells (CETC) and tumour stem cell subpopulations to therapy in the individual patient [J] . K.Pachmann, O.Camara, I.B.Runnebaum, European Journal of Cancer Supplements . 2009,第2期

机译：5156一种改善个性化癌症护理的工具：测量循环上皮肿瘤细胞（CETC）和肿瘤干细胞亚群对个别患者治疗的反应
2. Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment. [J] . Camara O, Jorke C, Hammer U, Journal of Cancer Research and Clinical Oncology . 2009,第4期

机译：监测循环上皮肿瘤细胞（CETC）以评估治疗方法：曲妥珠单抗后疾病进展的患者，通过联合拉帕替尼治疗可以消除持续存在的CETC。
3. Heterogeneity of circulating epithelial tumour cells from individual patients with respect to expression profiles and clonal growth (sphere formation) in breast cancer [J] . M Pizon, D Zimon, S Carl, Ecancermedicalscience . 2013,第1期

机译：个体患者循环上皮肿瘤细胞的异质性与乳腺癌的表达谱和克隆生长（球形成）有关
4. Multiplex Mesofluidic Device for Simultaneous Detection of Heterogeneous Viable Subpopulations of Circulating Tumor Cells (CTCs) in Cancer Patients [C] . Phuong Lan Tran, Stanislas Ropert, Francois Goldwasser, International Molecular Medicine Tri-Conference. . 2015

机译：用于同时检测癌症患者循环肿瘤细胞（CTCS）的异质活性群的多重细胞流体装置
5. A pilot study to evaluate KLK6 as a biomarker for the detection of circulating tumour cells in ovarian cancer patients. [D] . Oikonomopoulou, Aikaterini. 2004

机译：一项评估KLK6作为检测卵巢癌患者循环肿瘤细胞生物标志物的初步研究。
6. Circulating tumour cells as a predictive factor for response to systemic chemotherapy in patients with advanced colorectal cancer [O] . Silke Lankiewicz, Silke Zimmermann, Christiane Hollmann, 2008

机译：循环肿瘤细胞是晚期大肠癌患者全身化疗反应的预测因素
7. Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment [O] . 2009

机译：监测循环上皮肿瘤细胞（CETC）以评估治疗方法：曲妥珠单抗后疾病进展的患者，通过联合拉帕替尼治疗可以消除持续存在的CETC

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号